Oestrogen + other treatments vs placebo: Number with incontinence not improved (women's observations) ‐ oestrogen + progesterone vs placebo (Copy)
Oestrogen + other treatments leads to higher number with incontinence not improved (women's observations) ‐… compared with placebo (high certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Oestrogen + other treatments vs placebo Number with incontinence not improved (women's observations) ‐ oestrogen + progesterone vs placebo (Copy) · patients with urinary incontinence in post‐menopausal women Oestrogen + other treatments leads to higher number with incontinence not improved (women's observations) ‐… compared with placebo (high certainty). Oestrogen therapy for urinary incontinence in post‐menopausal women (2012) · Cochrane Headline outcomes only | RR 1.08 [1.01, 1.16] | 2 studies · 1514 participants | High |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Oestrogen therapy for urinary incontinence in post‐menopausal women 2012 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.